Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
McKesson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMIQUIMOD

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Imiquimod

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00031759 Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia Completed National Cancer Institute (NCI) Phase 2 1999-06-01 RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
NCT00031759 Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia Completed Alliance for Clinical Trials in Oncology Phase 2 1999-06-01 RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
NCT00066872 Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer Completed Queen's Medical Centre Phase 3 2002-10-01 RATIONALE: Biological therapies such as imiquimod use different ways to stimulate the immune system and stop cancer cells from growing. It is not yet known if topical imiquimod is more effective than surgery in treating basal cell skin cancer. PURPOSE: This randomized phase III trial is studying how well topical imiquimod works compared to surgery in treating patients with basal cell skin cancer.
NCT00079300 Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer Completed National Naval Medical Center Phase 1 2004-01-01 RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating patients with basal cell skin cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Imiquimod

Condition Name

Condition Name for Imiquimod
Intervention Trials
Actinic Keratosis 20
Actinic Keratoses 8
Cervical Intraepithelial Neoplasia 7
Lentigo Maligna 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Imiquimod
Intervention Trials
Keratosis, Actinic 33
Keratosis 33
Carcinoma 15
Carcinoma, Basal Cell 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Imiquimod

Trials by Country

Trials by Country for Imiquimod
Location Trials
United States 283
United Kingdom 19
Canada 10
Austria 10
Netherlands 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Imiquimod
Location Trials
New York 20
Florida 19
California 18
Illinois 15
Texas 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Imiquimod

Clinical Trial Phase

Clinical Trial Phase for Imiquimod
Clinical Trial Phase Trials
Phase 4 21
Phase 3 36
Phase 2/Phase 3 5
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Imiquimod
Clinical Trial Phase Trials
Completed 69
Recruiting 24
Not yet recruiting 17
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Imiquimod

Sponsor Name

Sponsor Name for Imiquimod
Sponsor Trials
National Cancer Institute (NCI) 15
Graceway Pharmaceuticals, LLC 15
MEDA Pharma GmbH & Co. KG 11
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Imiquimod
Sponsor Trials
Other 139
Industry 63
NIH 16
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.